WallStreetZenWallStreetZen

NASDAQ: RLAY
Relay Therapeutics Inc Stock Ownership - Who owns Relay Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Relay Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Donald A. BergstromPres2026-09-088,530$18.97
$161.81kSell
Thomas CatinazzoCFO2026-09-0817,717$18.94
$335.56kSell
Sanjiv PatelCEO;Pres2026-09-0848,199$18.94
$912.89kSell
Peter RahmerCXO2026-08-264,508$20.03
$90.30kSell
Svf Pauling Cayman Ltd10% Owner2026-08-256,000,000$19.40
$116.40MSell
Sanjiv PatelCEO;Pres2026-08-1748,199$20.33
$979.89kSell
Thomas CatinazzoCFO2026-08-1417,717$19.74
$349.73kSell
Thomas CatinazzoCFO2026-07-281,459$18.61
$27.15kSell
Donald A. BergstromPres2026-07-282,237$18.61
$41.63kSell
Peter RahmerCXO2026-07-28748$18.61
$13.92kSell

1 of 5

RLAY insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RLAY insiders and whales buy or sell their stock.

RLAY Shareholders

What type of owners hold Relay Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Svf Pauling Cayman Ltd22.73%49,809,926$920.99MInsider
Third Rock Ventures III LP4.81%10,551,115$195.09MInsider
Picularium LLC1.50%3,281,253$60.67MInsider
Sanjiv Patel1.05%2,293,306$42.40MInsider
Mark Murcko0.45%996,952$18.43MInsider
Alexandria Venture Investments LLC0.44%968,365$17.91MInsider
Donald A. Bergstrom0.18%399,130$7.38MInsider
Brian Adams0.17%371,472$6.87MInsider
Alexis Borisy0.11%234,175$4.33MInsider
Peter Rahmer0.10%223,657$4.14MInsider

1 of 3

RLAY vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RLAY0.11%31.68%Net SellingNet Selling
ABCL0.04%44.49%Net BuyingNet Buying
TNGX0.13%49.40%Net SellingNet Selling
EWTX0.11%14.46%Net SellingNet Selling
ADPT0.10%54.61%Net SellingNet Selling
View Top Biotech Stocks

Relay Therapeutics Stock Ownership FAQ

Who owns Relay Therapeutics?

Relay Therapeutics (NASDAQ: RLAY) is owned by 0.11% institutional shareholders, 31.68% Relay Therapeutics insiders, and 68.20% retail investors. Svf Pauling Cayman Ltd is the largest individual Relay Therapeutics shareholder, owning 49.81M shares representing 22.73% of the company. Svf Pauling Cayman Ltd's Relay Therapeutics shares are currently valued at $944.40M.

If you're new to stock investing, here's how to buy Relay Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.